声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。百时美施贵宝公司将终止与 Immatics 的两项细胞治疗合作,并取消与 Century Therapeutics 关于基于自然杀伤细胞和 T 细胞的癌症治疗的单独协议。这些似乎是百时美施贵宝 (Bristol Myers) 在 4 月份宣布的节省 15...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.